Human G protein-coupled receptors

Details Human G protein-coupled receptors Human G protein-coupled receptors

2006-05-04

2010-10-19

Landsman, Robert (Department: 1646)

Chemistry: natural resins or derivatives; peptides or proteins;

Proteins, i.e., more than 100 amino acid residues

C536S023500

Reexamination Certificate

active

07816492

ABSTRACT:
The invention disclosed in this patent document relates to transmembrane receptors, more particularly to endogenous, human orphan G protein-coupled receptors.

REFERENCES:
patent: 3197368 (1965-07-01), Lappe et al.
patent: 5462856 (1995-10-01), Lerner et al.
patent: 5514578 (1996-05-01), Hogness et al.
patent: 5532157 (1996-07-01), Fink
patent: 5573944 (1996-11-01), Kirschner et al.
patent: 5639616 (1997-06-01), Liao et al.
patent: 5750353 (1998-05-01), Kopin et al.
patent: 5891646 (1999-04-01), Barak et al.
patent: 5932445 (1999-08-01), Lal et al.
patent: 5942405 (1999-08-01), Ames et al.
patent: 6051386 (2000-04-01), Lerner et al.
patent: 6221660 (2001-04-01), Bonini et al.
patent: 6468756 (2002-10-01), Bonini et al.
patent: 6555339 (2003-04-01), Liaw et al.
patent: 6555344 (2003-04-01), Matsumoto et al.
patent: 6653086 (2003-11-01), Behan et al.
patent: 7083933 (2006-08-01), Griffin et al.
patent: 7108991 (2006-09-01), Chen et al.
patent: 2003/0064381 (2003-04-01), Feder et al.
patent: 2003/0125539 (2003-07-01), Bonini et al.
patent: 2003/0139590 (2003-07-01), Oshishi et al.
patent: 2003/0148450 (2003-08-01), Chen et al.
patent: 2003/0180813 (2003-09-01), Ohishi et al.
patent: 2008/0199889 (2008-08-01), Chen et al.
patent: 2135253 (1996-08-01), None
patent: 2362906 (2000-08-01), None
patent: 0860502 (1998-08-01), None
patent: 0899332 (1999-03-01), None
patent: 0913471 (1999-05-01), None
patent: 1075493 (2001-02-01), None
patent: 1 092 727 (2001-04-01), None
patent: 1092727 (2001-04-01), None
patent: 1338651 (2003-08-01), None
patent: WO 93/25677 (1993-12-01), None
patent: WO 97/11159 (1997-03-01), None
patent: WO 97/20045 (1997-06-01), None
patent: WO 97/21731 (1997-06-01), None
patent: WO 97/24929 (1997-07-01), None
patent: WO 98/00552 (1998-01-01), None
patent: WO 98/31810 (1998-07-01), None
patent: WO 98/34948 (1998-08-01), None
patent: WO 98/38217 (1998-09-01), None
patent: WO 98/39441 (1998-09-01), None
patent: WO 98/46995 (1998-10-01), None
patent: WO 98/50549 (1998-11-01), None
patent: WO 99/24463 (1999-05-01), None
patent: WO 99/24569 (1999-05-01), None
patent: WO 99/25830 (1999-05-01), None
patent: WO 99/42484 (1999-08-01), None
patent: WO 99/46378 (1999-09-01), None
patent: WO 99/52927 (1999-10-01), None
patent: WO 99/52945 (1999-10-01), None
patent: WO 99/52946 (1999-10-01), None
patent: WO 99/55732 (1999-11-01), None
patent: WO 99/55733 (1999-11-01), None
patent: WO 99/55734 (1999-11-01), None
patent: WO 99/64436 (1999-12-01), None
patent: WO 00/11015 (2000-03-01), None
patent: WO 00/11166 (2000-03-01), None
patent: WO 00/11170 (2000-03-01), None
patent: WO 00/22129 (2000-04-01), None
patent: WO 00/22131 (2000-04-01), None
patent: WO 00/23588 (2000-04-01), None
patent: WO 00/26369 (2000-05-01), None
patent: WO 00/28028 (2000-05-01), None
patent: WO 00/31258 (2000-06-01), None
patent: WO 00/42026 (2000-07-01), None
patent: WO 00/50562 (2000-08-01), None
patent: WO 00/12707 (2000-09-01), None
patent: WO 01/32864 (2001-05-01), None
patent: WO 01/36473 (2001-05-01), None
patent: WO 01/42288 (2001-06-01), None
patent: WO 01/87929 (2001-11-01), None
patent: WO 02/16548 (2002-02-01), None
patent: WO 02/44362 (2002-06-01), None
patent: WO 02/44362 (2002-06-01), None
patent: WO 02/64789 (2002-08-01), None
Bowie et al., Science 247: 1306-1310, 1990.
Wells, Biochemistry 29:8509-8517, 1990.
U.S. Appl. No. 09/416,760, filed Oct. 12, 1999, Chen et al.
Alla, S.A. et al., “Extracellular domains of the bradykinin B2 receptor involved in ligand binding and agonist sensing defined by anti-peptide antibodies,”J. Biol. Chem., 1996, 271, 1748-1755.
Advenier, C., et al., “Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors,” Am. Rev. Respir. Dis., 1992, 146 (5, Pt. 1), 1177-1181.
Alexander, W.S. et al., “Point mutations within the dimmer interface homology domain of c-Mpl induce constitute receptor activity and tumorigenicity,”EMBO J., 1995, 14(22), 5569-5578.
Arvanitikis, L. et al., “Human herpesvirus KSHV encloses a constitutively active G-protein-coupled receptor linked to cell proliferation,”Nature, 1997, 385, 347-349.
Barker, E.L., et al., “Constitutively active 5-hydroxytryptamine2creceptors reveal novel inverse agonist activity of receptor ligands,”J. Biol. Chem., 1994, 269(16). 11687-11690.
Baxter G., “5-HT2receptors: a family re-united?”Trends Pharmacol. Sci., 1995, 16, 105-110.
Bentley, “Genomic sequence information should be release immediately and freely to the public,” The Sanger Institute: Human Genome Project, Policy Forum,Science(1996) 274:533-534.
Bergsma, et al., “Cloning nad characterization of a human angiotensin II type 1 receptor,”Biochem, Biophs. Res. Comm. (1992) 183:989-995.
Berridge, “Inositol triphosphate and calcium signaling,”Nature(1993) 361:315-325.
Bertin, et al, “Cellular signaling by an agonist-activated receptor/Gs-alpha protein,”Proc. Natl. Acad. Sci. USA(1994) 91:8827-8831.
Besmer, P. et al., “A new acute transforming feline retrovirus and relationship of its oncognenev-kitwith the protein kinase gene family,”Nature(1986) 320, 415-421.
Bhathena, et al., “Insulin, glucagon and somatostatin secretion by cultured rat islet cell tumor and its clones,”Proc. Soc. Exptal. Biol. Med. (1984) 175:35-38.
Blaszczyk, “Motor deficiency in Parkinson's disease,”Acta Neurobiol exp(1998) 58:79-93.
Blin, N. et al., “Mapping of single amino acid residues required for selective activation of Gq/11by the m3 muscarinic acetylcholine receptor,”J. Biol. Chem., 1995, 270, 17741-17748.
Bond, R.A. et al., “Inverse agonists and G-protein-coupled receptors,” inReceptor-Based Drug Design, Leff, P. (ed.), New York, M. Dekker, 1998, 363-377.
Boone, C. et al., “Mutations that alter the third cytoplasmic loop of the a-factor receptor lead to a constitutive and hypersensitive phenotype,”Proc. Natl. Acad. Sci. USA, 1993, 90(21), 9921-9925.
Breier, “In situ hybridization with RNA probes,”Methods Mol Biol(1999) 95:107-117.
Broun, P., et al., “Catalytic Plasticity of Fatty Acid Modification Enzymes Underlying Chemical Diversity of Plant Lipids,”Science, 282:1315-1317, (Nov. 13, 1998).
Burstein, E.S. et al., “Constitutive activation of chimeric m2/m5 muscarinic receptors and delineation of G-protein coupling selectivity domains,”Biochem. Pharmacol., (1996), 51(4), 539-544.
Burstein, E.S. et al., “Amino acid side chains that define muscarinic receptor/G-protein coupling. Studies of the third intracellular loop,”J. Biol. Chem., (1996), 271(6), 2882-2885.
Burstein, E.s. et al., “Constitutive activation of muscarinic receptors by the G-protein Gq”FEBS Lett., (1995), 362(3), 261-263.
Burt, et al., “Agonist occupation of an alpha-2A-adrenoreceptor-Gi1-alpha fusion protein results in activation of both receptor-linked and endogenous Gi proteins,”J. Biol. Chem. (1997) 283:10367-10375.
Bylund, D., “International union of pharmacology nomenclature of adrenoceptors,”Pharrmacol. Rev., (1994), 46, 121-136.
Casey, C. et al., “Constitutively active mutant 5-HT2Aantagonists,”Soc. Neurosci., 1996, Abstract #699.10.
Cheatham, B. et al., “Substitution of the erbB-2 oncoprotein transmembrane domain activates the insulin receptor and modulates the action of insulin-receptor substrate 1,”Proc. Natl. Acad. Sci. USA, 1993, 90, 7336-7340.
Chen, J. et al., “Tethered Ligand Library for Discovery of Peptide Agonists,”J. Biol. Chem., 1995, 270, 23398-23401.
Chen, T.A. et al., “Microbial hydroxylation and glucuronidation of the angiotensin II (AII) receptor antagonist MK 954,”J. Antibiot. (Tokyo), 1993, 46(1) 131-134.
Chen, W. et al., “A colorimetric assay for measuring activation of Gs- and Gq-coupled signaling pathways,”Anal. Biochem., 1995, 226(2), 34

Affiliated with

Also associated with

Rating

Human G protein-coupled receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Human G protein-coupled receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human G protein-coupled receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4240700